January 15th, 2008
TOP2A FISH pharmDx: New Genetic Test for Breast Cancer, FDA-Approved
Approved by the FDA, a genetic test that can help in the assessment of risk of tumor recurrence and long-term survival for patients with relatively high-risk breast cancer - TOP2A FISH pharmDx - is the first approved device to test for the TOP2A (topoisomerase 2 alpha) gene in cancer patients.
The TOP2A gene plays a role […]
Recent Comments